Harrow Health, Inc. Banner Image

Harrow Health, Inc.

  • Ticker HROW
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Harrow Health, Inc. Logo Image
  • 51-200 Employees
  • Based in Nashville, Tennessee
Harrow Health, Inc. (NASDAQ: HROW) owns a portfolio of healthcare businesses, including ImprimisRx, the nation’s leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, and Melt Pharmaceuticals. Harrow also owns Mayfield Pharmaceuticals, Stowe Pharmaceuticals, and VisionologyMore, all companies founded as subsidiaries of Harrow Health. The Company also owns royalty rights in certain drug candidates being developed by Surface, Melt, and Mayfield. Harrow intends to create, invest in and grow paradigm shifting healthcare businesses that put patients first.
5.0 / 5.0 (1)

Harrow Health, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Harrow Health, Inc.

Most Recent Responsibility Report

Harrow Health, Inc.
MOST RECENT 2022 Corporate Transparency Report

Harrow Health, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Harrow Health, Inc. Sustainability Report, Harrow Health, Inc. Corporate Social Responsibility Report, Harrow Health, Inc. CSR Report, Harrow Health, Inc. Corporate Responsibility, Harrow Health, Inc. CR Report, Harrow Health, Inc. Citizenship Report, Harrow Health, Inc. ESG Report, and Harrow Health, Inc. Environmental Report online.
Harrow Health, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!